Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. - Wikidata - awgldk - TriplyDB

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.

http://www.wikidata.org/entity/Q34524792

about

Cannabis and tobacco smoke are not equally carcinogenic.Killing tumours by ceramide-induced apoptosis: a critique of available drugs Is lipid signaling through cannabinoid 2 receptors part of a protective system?The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin The endocannabinoid system as an emerging target of pharmacotherapy The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay Harm reduction--the cannabis paradox Epigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in Offspring Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.Synthetic Cannabinoid-Induced Immunosuppression Augments Cerebellar Dysfunction in Tetanus-Toxin Treated Mice.Cannabinoids as novel anti-inflammatory drugs.Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates.The non-psychoactive plant cannabinoid, cannabidiol affects cholesterol metabolism-related genes in microglial cells.Stabilization of functional recombinant cannabinoid receptor CB(2) in detergent micelles and lipid bilayers.Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma.Hypothesizing that marijuana smokers are at a significantly lower risk of carcinogenicity relative to tobacco-non-marijuana smokers: evidenced based on statistical reevaluation of current literature.Endocannabinoids and immune regulation.Cannabidiol as potential anticancer drug.CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties Cannabinoids attenuate cancer pain and proliferation in a mouse model Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model.The cannabinoid system and immune modulation.Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells.Cannabinoid receptor systems: therapeutic targets for tumour intervention.CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents.Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation.Cannabidiol inhibits angiogenesis by multiple mechanisms.New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptors.Modulating the endocannabinoid system in human health and disease--successes and failures Cannabinoids:their role in pain and palliation.The analgesic potential of cannabinoids.

P2860

Q21245633-B0589E58-A816-47F5-842A-D2237945F04C Q24529892-2D384589-F6CD-404C-AA4B-1B3D89C56AC3 Q24633122-6C53605B-62C1-409F-B319-48AAFCE00D7B Q24643876-B7C07F2E-BA74-4CEF-81E2-6E92357073B4 Q24648473-9FA10C4B-CE67-4FC6-A37A-0115BDE38487 Q24651712-67BCA5E0-B95D-45D9-B561-7984B09395C5 Q24654730-5F78D00E-54C5-4445-A2FF-95CC19E7F09D Q24814542-F1709792-B070-4C47-8BE1-51E60B5C02C9 Q26864359-3FA113CF-E1C9-4427-BC52-C1B91BFE685C Q28075341-952A6D86-A2D5-4177-A20B-14B8B23B7343 Q33623423-F2241D0D-5289-45CE-877B-C88643E18918 Q33655884-BE556200-6EBA-4556-9FC6-B60E1A225C0F Q33688381-A0E9BCE4-1260-4463-92B9-2933DFBD9FE0 Q33960952-12BD5C94-CD4A-48A9-8261-3C02D2413B6A Q34069579-EF14C2B1-BCEE-4E65-AAC2-0773F423BDBE Q34177133-C59FDDD9-07D2-4C22-B9E8-E89C2A6537C5 Q34181605-927E2F0D-15DE-4BE3-B543-747910659DD1 Q34441289-DD8D3543-5519-4A44-B6A5-5D3F50EC1271 Q34563164-CB98FFC7-C50D-45AD-9401-2F48273AD463 Q34600163-85D1FC2C-7A1A-4CC0-9161-DD6BAB658C36 Q34607419-2475C1A9-4B2B-4389-84C1-3872152AD50A Q34637516-42E7CD90-ADB1-41F4-A6FB-900A7B28B290 Q34733645-3E92D0F7-E8A4-43E5-AD41-153775BE46B8 Q34789214-11BB6328-FC4D-415F-9C13-6C08988C91D7 Q34997343-D65A5A49-BB78-4807-BCD6-75D59B1BC815 Q35188151-3DC50329-A03B-4D53-82BE-B5306766A58A Q35213813-4B80D4B0-A7B8-407B-A8E9-85D7FB030B56 Q35429696-666E7CE9-0AED-4A2F-9898-38ACB0209E8B Q35572084-55F68A8A-3317-4F22-99A9-4B6C4627AF85 Q35593944-AAA98EDC-674B-4C06-A8DD-B33895DC094A Q35781582-E0D29263-9BE9-4D93-964C-8AAB0976BFF1 Q35847290-730763BE-7393-4E91-A6AC-D71F1829EA73 Q35896078-1EE384E4-E296-4D9D-9C2D-96428ED96C06 Q36015427-C6D9FD04-8EF2-4C8D-B5C4-67BB47340D55 Q36036102-26357285-267F-4EB4-81DE-D0B13FEF9DDD Q36419293-5D0078AC-11DD-4246-B99B-9092E3FCE8A6 Q36659848-617D06C5-19B6-47C8-B888-9F58BC8609DE Q36933683-7CB0B9BE-5A24-447D-94E0-4B77BABA3C67 Q37010970-1608776C-B0E2-4B0E-A6DD-24A14E2D3A9D Q37057325-1C010C51-6811-4868-9748-6B00B6CC0708

P2860

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.

http://www.wikidata.org/entity/Q34524792

description

2002 nî lūn-bûn

@nan

2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Targeting CB2 cannabinoid rece ...... lignant lymphoblastic disease.

@ast

Targeting CB2 cannabinoid rece ...... lignant lymphoblastic disease.

@en

Targeting CB2 cannabinoid rece ...... lignant lymphoblastic disease.

@nl

type

label

Targeting CB2 cannabinoid rece ...... lignant lymphoblastic disease.

@ast

Targeting CB2 cannabinoid rece ...... lignant lymphoblastic disease.

@en

Targeting CB2 cannabinoid rece ...... lignant lymphoblastic disease.

@nl

prefLabel

Targeting CB2 cannabinoid rece ...... lignant lymphoblastic disease.

@ast

Targeting CB2 cannabinoid rece ...... lignant lymphoblastic disease.

@en

Targeting CB2 cannabinoid rece ...... lignant lymphoblastic disease.

@nl

P1433

Q34524792-DDB0E280-11DB-4810-8B7A-080D47E9E72E

P1476

Q34524792-20024566-F221-45D4-9739-09E81B0DF5D3

P2093

Q34524792-1DB51460-C0EB-469E-9BC3-6AE44879F90D

Q34524792-2FA3EF5B-9D6F-4107-A3A7-F0B0EFAE6119

Q34524792-311255EC-B6D7-4A65-AA92-25EE27B454EC

Q34524792-53F2432F-E514-4724-84BA-E8A1CD53EE1E

Q34524792-62912364-46BB-4E48-AF6E-462A2B4078ED

Q34524792-6C7C483A-5AB6-476A-A309-80778A6D32EF

Q34524792-E03A1052-653B-416B-9B32-BC7138986545

P304

Q34524792-4F279D6F-1378-4A9A-AB9C-42856B992007

P31

Q34524792-1591C4A3-A17F-42DD-BFFC-96D163108DAE

P356

Q34524792-0DB0B865-F7DE-4BA6-A696-BAC0DFBD763B

P407

Q34524792-B8F7E1B9-F545-40E3-B76B-BF6417A6D54D

P433

Q34524792-01BFBC73-9A28-4DF5-A8DA-CE46514CC7E5

P478

Q34524792-51B5C3F7-6DEE-4F43-B90B-272875BE9CC9

P50

Q34524792-CD676E83-9CC8-4199-A6CE-4BEAF53070B1

P577

Q34524792-E21CA2F0-4F13-4920-83AD-5CBC46F4060D

P5875

Q34524792-829ECC9E-757F-40FE-8939-3C31B3041F95

P698

Q34524792-851EC196-6CF8-4B35-B946-9FD54CC43E0D

P921

Q34524792-51D03779-2CAC-4622-8E6E-4BAE8E295A0E

Q34524792-784aee64-e8fb-4edf-a4d4-37d7612719fb

Q34524792-9B70E020-C2DC-4BE7-93D3-73E18165D9B7

P356

BLOOD-2002-01-0098

P1433

P1476

Targeting CB2 cannabinoid rece ...... lignant lymphoblastic disease.

@en

P2093

Catherine Lombard

http://www.w3.org/2001/XMLSchema#string

Michael Fisher

http://www.w3.org/2001/XMLSchema#string

Mitzi Nagarkatti

http://www.w3.org/2001/XMLSchema#string

Prakash S Nagarkatti

http://www.w3.org/2001/XMLSchema#string

Robert J McKallip

http://www.w3.org/2001/XMLSchema#string

Seongho Ryu

http://www.w3.org/2001/XMLSchema#string

Steven Grant

http://www.w3.org/2001/XMLSchema#string

P304

627-634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2002-01-0098

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11284984

http://www.w3.org/2001/XMLSchema#string

P698

12091357

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoid receptor